Adma Biologics reported $114.12M in Stock for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Adma Biologics ADMA:US $ 114.12M 14.42M
Agile Therapeutics AGRX:US 3.46M 2K
Alnylam Pharmaceuticals ALNY:US $ 110.95M 26.59M
Antares Pharma ATRS:US $ 16.49M 2.15M
Biocryst Pharmaceuticals BCRX:US $ 13.66M 3.82M
Dynavax Technologies DVAX:US $ 67.3M 19.15M
Novavax NVAX:US $ 0 0
Omeros OMER:US $ 712K 266K
Takeda 4502:JP Y 783476M 4328M